FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system

OBJECTIVE: Available chemotherapy presents poor control over the development of metastatic melanoma. FTY720 is a compound already approved by the Food and Drug Administration for the treatment of patients with multiple sclerosis. It has also been observed that FTY720 inhibits tumor growth in vivo (e...

Full description

Bibliographic Details
Main Authors: Felipe V. Pereira, Denise C. Arruda, Carlos R. Figueiredo, Mariana H. Massaoka, Alisson L. Matsuo, Valquiria Bueno, Elaine G. Rodrigues
Format: Article
Language:English
Published: Elsevier España 2013-07-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013000701018&lng=en&tlng=en